Curcumin (diferuloylmethane) delivery methods: A review

BioFactors

Volumn 39, Issue 1, 2013, Pages 21-26

  Helson, Lawrence ^a  

^a SignPath Pharma   (United States)

Author keywords

Curcumin; Delivery; Diferuloylmethane; Preventative; Systemic; Therapeutic; Topical

Indexed keywords

CURCUMIN; PIPERINE;

ANTIARRHYTHMIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; BLOOD BRAIN BARRIER; CELL PROLIFERATION; CELL SURVIVAL; CELLULAR SECRETION; CONTROLLED RELEASE FORMULATION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG ERUPTION; DRUG GLUCURONIDATION; DRUG INDUCED HEADACHE; DRUG RELEASE; DRUG SOLUBILITY; DRUG SULFATION; HEART REPOLARIZATION; HUMAN; INFLAMMATION; LIPOPHILICITY; MICROEMULSION; NONHUMAN; OXIDATIVE STRESS; PANCREAS CANCER; PARTICLE SIZE; PRIORITY JOURNAL; REVIEW;

ADMINISTRATION, INTRANASAL; ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOLOGICAL AVAILABILITY; CURCUMIN; DELAYED-ACTION PREPARATIONS; HUMANS; INJECTIONS; SUPPOSITORIES; TISSUE DISTRIBUTION;

EID: 84874105550     PISSN: 09516433     EISSN: 18728081     Source Type: Journal    
DOI: 10.1002/biof.1080     Document Type: Review

References (36)

1. Parveen, S. and Sahoo, S. K. ( 2008) Polymeric nanoparticles for cancer therapy. J. Drug Target 16, 108-123.
2. Helson, L., Bolger, G., Majeed, M., Pucaj, K., Matabudul, D. et al. ( 2012) Infusion pharmacokinetics of lipocure TM and its metabolite tetrahydrocurcumin in Beagle Dogs. J. Anticancer Res. 32:4365-4370.
3. Hassaninasab, A., Hashimoto, Y., Tomita-Yokotani and Kobayashi M. ( 2011) Discovery of the curcumin metabolic pathway involving a unique enzyme in a intestinal microorganism. Proc. Natl Acad. Sci. USA 108, 6615-6620.
4. Krishnakumar, I. M., Abhilash R., Kumar D., Kuttan, R. and Maliakel, B. ( 2012) An enhanced bioavailable formulation of curcumin using fenugreek-derived soluble dietary fibre. J. Funct. Foods 4, 348-357.
5. Shoba, G., Joy, D., Joseph, T., Majeed, M., Rajendran, R. et al. ( 1998) Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med. 64, 353-356.
6. Helson, L. ( 2011) Liposome mitigation of curcumin inhibition of cardiac potassium delayed -rectifier current. Journal of Receptor, Ligand and Channel Research 5:1-8.
7. Moha ou Mati, H., Ducroq, J., Rivet J., Faivre, J. F., LeGrande, M. et al. ( 2008) Curcumin blocks the recombinant human cardiac KCNQ1/KCNE1 channels(IKs) stably expressed in HEK 293 cells. Congress de Physiologie, de Pharmacologie et de Therapeutique, Clermont-Ferrand, France, Fund Clin. Pharmacol. 22 ( Suppl. 1).
8. Hu, C. W., Sheng, Y., Zhang, Q., Liu, H. B., Xie, X. et al. ( 2012) Curcumin inhibits hERG potassium channels in vitro. Toxicol Lett. 208, 192-196.
9. Li, L., Braiteh, F. S., and Kurzrock, R. ( 2005) Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis. Cancer 104, 1322-1331.
10. Sharma, R. A., McLelland, H. R., Hill, K. A. et al ( 2004) Pharmacodynamic and Pharmacokinetic study of oral curcuma extract in patients with colorectal cancer. Clin. Cancer Res. 10, 6847-6854.
11. Renu, A., Kanwar, K., and Kanwar, M. ( 2007) Effects of curcumin on retinal oxidative stress and inflammation in diabetes. Nutr. Metab. 4, 1743-1748.
12. Matabudul, D., Picaj, K., Bolger, G., Vcelar, B., Majeed, M. et al. ( 2012) Tissue distribution of lipocurc™ liposomal curcumin and tetrahydrocurcumin following two and eight hour infusions in Beagle Dogs. J. Anticancer Res. 32, 4359-4364.
13. Begum, A. N., Jones, M. R., Lim, G. P. et al. ( 2008) Curcumin structure -function, bioavailibility, and efficacy in models of neuroinflammation and Alzheimers disease. J. Pharmacol. Exp. Ther. 326, 196-208.
14. Bisht, S., Feldmann, G., Soni, S., Ravi, R., Karikar, C. et al. ( 2007) Polymeric nanoparticle-encapsulated curcumin ('nanocurcumin'): a novel strategy for human cancer therapy. J. Nanobiotech. 5, 3.
15. Shahani, K. and Panyam, J. ( 2011) Highly loaded, sustained-release microparticles of curcumin for chemoprevention. J. Pharm. Sci. 100, 2599-2609.
16. Singletary, K., MacDonald, C., Wallig, M., and Fisher, C. ( 1996) Inhibition of 7, 12- dimethylbenz[a]anthracene (DMBA)-induced mammary tumorigenesis and DMBA-DNA adduct formation by curcumin. Cancer Lett. 103, 137-141.
17. Parveen, S. and Sahoo, S. K. ( 2008) Polymeric nanoparticles for cancer therapy. J Drug Target. 16, 108-123.
18. Vishwanatha, J. K. ( 2010) Formulation of active agent-loaded activated PLGA nanoparticles for targeted cancer nanotherapeutics. US Patent Application Publication: No. 2008/0253961 A1.
19. Jang, H. S., Nam, H. Y., Kim, J. M. et al. ( 2009) Curcumin for preventing restenosis in a hypercholesterolemic rabbit iliac artery stent model. Catheter. Cardiovas. Interv. 74, 881-888.
20. Lal, B., Kapoor, A. K., Asthana, O. P., Agrawal, P. K., Prasad, R. et al. ( 1999) Efficacy of curcumin in the management of chronic anterior uveitis. Phytother. Res. 13, 318-322.
21. LoTempio, M. M., Veena, M. S., Steele, H. L., Ramamurthy, B., et al. ( 2005) Curcumin suppresses growth of head and neck squamous cell carcinoma. Clin. Cancer Res. 11, 6994-7002.
22. Sindhwani, P., Hampton, J. A., Baig, M. M., Keck, R., Selman, S. H. ( 2001) Curcumin prevents intravesical tumor implantation of the MBT-2 tumor cell line in C3H mice. J. Urol. 166, 1498-1501.
23. DiMauro, T. M. ( 2006) Intranasally administering curcumin to the brain to treat Alzheimer's disease. Patent # 2008/0075671A1.
24. Patel, B. M., Mandal, S., Rajesh, K. S. ( 2012) Formulation and kinetic modeling of curcumin loaded intranasal mucoadhesive microemulsion. J. Pharm. Bioall. Sci. 4, 81-83.
25. Csaba, N., Garcia -Fuentes, M., and Alonso, M. J. ( 2006) The performance of nanocarriers for transmucosal drug delivery. Expert Opin. Drug Deliv. 3, 463-478.
26. Turlej, R. K., Fiévez, L., Sandersen, C. F., Dogné, S., Kirschvink, N. et al. ( 2001) Enhanced survival of lung granulocytes in an animal model of asthma: evidence for a role of GM-CSF activated STAT5 signalling pathway. Thorax 56, 696-702.
27. Moran, G. and Folch, H. ( 2011) Recurrent airway obstruction in horses an allergic inflammation: a review. Veter. Med. 56, 1-13.
28. Rennolds, J., Malireddy, S., Hassan, F., Tridandapani, S., Parinandl, N., et al. ( 2012) Curcumin regulates airway epithelial cell cytokine responses to the pollutant cadmium. Biochem. Biophys. Res. Commun. 417, 256-261.
29. Sandersen, C., Olejnik, D., Franck, T., Neven, P., Serteyn, D. et al. ( 2011) Inhalation with NDS27 attenuates pulmonary neutrophilic inflammation in recurrent airway obstruction. Veter. Record. 169, 101.
30. Life Extention Inc. Fort Lauderdale Florida, USA.
31. Kim, M. S., Yoon, M. H., and Kim, W. M. ( 2012) Analgesic effects of intrathecal curcumin in the rat formalin test. Korean J. Pain 25, 1-6.
32. Zhao, X., Xu, Y., Zhao, Q., Chen, C. R., Liu, A. M. et al. ( 2012) Curcumin exerts anti-nociceptive effects in a mouse model of neuropathic pain: descending monamine system and opioid receptors are differentially involved. Neuropharmacology 62, 843-854.
33. Zheng, J., Zheng, C., Cao, H, Li, J., and Lian, Q. ( 2011) Curcumin downregulate CX3CR1 expression in spinal cord dorsal horn and DRG in neuropathic pain rats. Zhongguo Zhong Yao Za Zh 36, 2552-2556.
34. Antony, S., Kuttan, R., and Kuttan, G. ( 1999) Immunomodulatory activity of curcumin. Immunol. Invest. 28, 291-303.
35. Vishvakarma, N. K., Kumar, A., Kumar, A. J., Kant, S., Bharti, A. C. et al. ( 2012) Myelopotentiating effect of curcumin in tumor-bearing host: role of bone marrow resident macrophages. School of Biotechnology, Banaras Hindu University, Varanasi-221 005, U.P., India.
36. Gupta, R. C., Bansal, S., Aqil, F., Jeyabalan, J., Cao, P. et al. ( 2012) Carcinogenesis. Jun 13. [Epub ahead of print].